Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness
Jr. Bower et al., Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness, J VIROLOGY, 73(5), 1999, pp. 3843-3853
Two intrastrain variants of herpes simplex virus type 1 (HSV-1) were isolat
ed from a newborn with fatal disseminated infection. A small-plaque-produci
ng variant (SP7) was the predominant virus (>99%) in the brain, and a large
-plaque-producing variant (LP5) was the predominant virus (>99%) in the lun
g and gastrointestinal tract. EcoRI and BamHI restriction fragment patterns
indicated that SP7 and LP5 are related strains. The large-plaque variants
produced plaques similar in size to those produced by HSV-1 KOS. Unlike LP5
or KOS, SP7 was highly cell associated and processing of glycoprotein C an
d glycoprotein D was limited to precursor forms in infected Vero cells. The
large-plaque phenotype from KOS could be transferred into SP7 by cotransfe
ction of plasmids containing the EK or JK EcoRI fragment or a 3-kb plasmid
with the UL34.5 gene of HSV-1 KOS together with SP7 DNA. PCR analysis using
primers from within the ICP34.5 gene indicated differences for SP7, LP5, a
nd KOS. Sequencing data indicated two sets of deletions in the UL34.5 gene
that distinguish SP7 from LP5. Both SP7 and LP5 variants were neurovirulent
(lethal following intracranial inoculation of young BALB/c mice); however,
the LP5 variant was much less able to cause lethal neuroinvasive disease (
footpad inoculation) whereas KOS caused no disease. Passage of SP7 selected
for viruses (SLP-5 and SLP-10) which were attenuated for lethal neuroinvas
ive disease, were not cell-associated, and differed in the UL34.5 gene. UL3
4.5 from SLP-5 or SLP-10 resembled that of KOS. These findings support a ro
le for UL34.5 in promoting virus egress and for neuroinvasive disease.